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Purpose of the study
Osteonecrosis (ON) represents a rare but increasingly
reported metabolic complication in patients with
advanced HIV infection. It has been related to a number
of behavioural and immunological risk factors, as well as
to the duration of both HIV infection and antiretroviral
therapy. We retrospectively investigated the incidence of
ON at our institution in the HAART era, and designed a
case-control study to look for potential predictors of dis-
ease.
Methods
Between 1997 and 2007, all incident cases among the 237
patients treated with any line of HAART for a mean of 37
months were characterized by standard Rx scans, bone
scintigraphy and selective computed tomography or MRI
scan of the interested district(s). We evaluated age, sex,
BMI, cigarette smoking and alcohol abuse, QUS-meas-
ured bone density, CD4 T-cell counts, HIV viral load,
duration of HIV infection and HAART, use of steroids,
blood glucose, total cholesterol and triglicerides, total
serum IgE levels, presence of autoantibodies and lipodys-
trophy. A control group of HIV patients on HAART was
selected, without ON and matched for age, sex and nadir
CD4 T-cells at the start of therapy.
Summary of results
Eight patients were diagnosed with ON (3.4%); 16 con-
trols were selected. Among cases, five were males, with a
mean age of 39.5 years and nadir CD4 T-cells 110 ± 52/
mm3; four had hip, four had knee involvement, bilateral
in two cases for each site. All cases presented due to long-
lasting localized pain; one was also diagnosed with a sec-
ondary bone fracture. Statistical analysis revealed a signif-
icant association of ON with exposure to steroids (p =
0.001), multiple co-morbidities (p = 0.032) and exposure
to more drugs (p = 0.012), and high titres of total IgE (p <
0.01). Immune recovery, cigarette smoking and bone den-
sity among all other factors investigated were not related.
Conclusion
Our investigation confirms that ON is not rare during
long-term treatment of HIV infection. Better knowledge of
the condition, furthermore, may help prompt diagnosis of
incident cases in the future. Patients at higher risk have
concomitant advanced HIV infection at diagnosis, pres-
ence of multiple co-morbidities and treatment with other
drugs in addition to HAART, long-term exposure to ster-
oids and high levels of serum IgE immunoglobulins. Cig-
arette smoking was very frequent both among cases and
controls and its contributory role to disruption of bone
microvasculature cannot therefore be excluded by our
experimental design.
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